Literature DB >> 7594769

The involvement of endogenous nitric oxide in vagal-cholinergic stimulation of exocrine and endocrine pancreas in dogs.

J Bilski1, J W Konturek, S J Konturek, W Domschke.   

Abstract

Previous studies showed that nitric oxide (NO), synthesized from L-arginine (L-arg) by NO synthase (NOS) in vascular epithelium and nerve terminals, affects exocrine pancreatic secretion, but its role in control of endocrine pancreas has not been studied. In this study, the role of NO in the control of pancreatic secretion in response to vagal-cholinergic stimulation and duodenal infusion of nutrients was determined in conscious dogs with chronic pancreatic fistulas. Sham feeding (SF), urecholine iv infusion, and duodenal perfusion with nutrients were used to stimulate the pancreatic protein secretion, and insulin and glucagon release in tests without and with iv infusion of NG-nitro-L-arginine (L-NNA), an inhibitor of NO synthase, L-arg, a substrate of NOS, or their combination was used. SF, urecholine, and duodenal nutrient resulted in the stimulation of pancreatic protein secretion reaching, respectively, 50, 20, and 42% of cerulein maximum. Infusion of L-arg almost doubled the basal protein secretion and tended to increase the secretory response to SF and duodenal nutrient. After infusion of L-NNA, the pancreatic secretory responses to SF, urecholine, and duodenal nutrient were inhibited by about 70, 30, and 75%, respectively. When L-arg was combined with L-NNA, the reduction in pancreatic secretion by L-NNA was significantly attenuated. SF resulted in a significant rise in plasma insulin and glucagon, and this response was completely abolished by L-NNA infusion. Urecholine and duodenal nutrient also resulted in a marked increment in plasma insulin and glucagon, the insulin (but not glucagon) increment being abolished by the pretreatment with L-NNA and reversed by the addition of L-arg.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594769     DOI: 10.1007/BF02825420

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  25 in total

1.  Nitric oxide and arginine-evoked insulin secretion.

Authors:  S R Vincent
Journal:  Science       Date:  1992-11-20       Impact factor: 47.728

2.  Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs.

Authors:  S J Konturek; W Bielański; T E Solomon
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

3.  L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.

Authors:  S G Laychock; M E Modica; C T Cavanaugh
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

4.  Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay.

Authors:  C A Delaney; M H Green; J E Lowe; I C Green
Journal:  FEBS Lett       Date:  1993-11-01       Impact factor: 4.124

5.  Nitric oxide production regulates cGMP formation and calcium influx in pancreatic acinar cells.

Authors:  A Gukovskaya; S Pandol
Journal:  Am J Physiol       Date:  1994-03

6.  NADPH-diaphorase activity in neurons of the mammalian pancreas: coexpression with vasoactive intestinal polypeptide.

Authors:  T Shimosegawa; T Abe; A Satoh; R Abe; Y Kikuchi; M Koizumi; T Toyota
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

7.  Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides.

Authors:  H H Schmidt; T D Warner; K Ishii; H Sheng; F Murad
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

8.  Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.

Authors:  J A Corbett; M A Sweetland; J L Wang; J R Lancaster; M L McDaniel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

10.  Role of nitric oxide in neurally induced pancreatic exocrine secretion in pigs.

Authors:  J J Holst; T N Rasmussen; P Schmidt
Journal:  Am J Physiol       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.